Literature DB >> 8775165

Assessment of chlorine exposure in swimmers during training.

F Drobnic1, A Freixa, P Casan, J Sanchis, X Guardino.   

Abstract

The presence of a high prevalence of bronchial hyperresponsiveness and asthma-like symptoms in swimmers has been recently reported. Chlorine, a strong oxidizing agent, is an important toxic gas that the swimmer can breath during swimming. Measurements of the chlorine concentration at the breathing level (< 10 cm) were obtained randomly during five nonconsecutive days in four different swimming pool enclosures. The mean level in all the swimming pools was 0.42 +/- 0.24 mg.m-3, far below the threshold limited value (TLV) of 1.45 mg.m-3 for the work places for a day of work (8 h). The TLV could be reached and even exceeded if we consider the total amount of chlorine that a swimmer inhales in a daily training session of 2 h (4-6 g) compared with a worker during 8 h at the TLV (4-7 g). Low correlation was observed with the number of swimmers in the swimming pool during the measurements (0.446) and other variables as the water surface area of the pool, volume of the enclosure, and the chlorine-addition system in the swimming pool. A low turnover rate in the air with an increase of chlorine levels through the day (P < 0.05) was observed in all pools. The concentration of chlorine in the microenvironment where the swimmer is breathing is below the TLV concentration limit, but nevertheless results in a high total volume of chlorine inhaled by the swimmers in a given practice session. The possible role of chlorine in producing respiratory symptoms in swimmers needs further investigation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8775165     DOI: 10.1097/00005768-199602000-00018

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  16 in total

1.  Alterations in rhinosinusal homeostasis in a sportive population: our experience with 106 athletes.

Authors:  Desiderio Passàli; Valerio Damiani; Giulio Cesare Passàli; Francesco Maria Passàli; Luisa Bellussi
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-17       Impact factor: 2.503

2.  Prevalence of obstructive airflow limitation in Irish collegiate athletes.

Authors:  E Smith; N Mahony; B Donne; M O'Brien
Journal:  Ir J Med Sci       Date:  2002 Oct-Dec       Impact factor: 1.568

Review 3.  Inhaled beta2 agonists and performance in competitive athletes.

Authors:  W Kindermann; T Meyer
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

Review 4.  Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?

Authors:  Wilfried Kindermann
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

5.  Swimming versus running: effects on exhaled breath condensate pro-oxidants and pH.

Authors:  Oscar F Araneda; Felipe Contreras-Briceño; Gabriel Cavada; Ginés Viscor
Journal:  Eur J Appl Physiol       Date:  2018-08-09       Impact factor: 3.078

Review 6.  Prevalence and mechanisms of development of asthma and airway hyperresponsiveness in athletes.

Authors:  J B Langdeau; L P Boulet
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 7.  Asthma, airway inflammation and treatment in elite athletes.

Authors:  Ilkka Helenius; Aki Lumme; Tari Haahtela
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 8.  The respiratory health of swimmers.

Authors:  Valérie Bougault; Julie Turmel; Benoît Levesque; Louis-Philippe Boulet
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

9.  Exercise-induced bronchoconstriction and atopy in Tunisian athletes.

Authors:  Ridha Sallaoui; Karim Chamari; Abbas Mossa; Zouhair Tabka; Moktar Chtara; Youssef Feki; Mohamed Amri
Journal:  BMC Pulm Med       Date:  2009-02-05       Impact factor: 3.317

Review 10.  Special considerations for adolescent athletic and asthmatic patients.

Authors:  Jan C Wuestenfeld; Bernd Wolfarth
Journal:  Open Access J Sports Med       Date:  2013-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.